Morgan Stanley Anika Therapeutics, Inc. Call Options Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIK
# of Institutions
119Shares Held
11.9MCall Options Held
5.9KPut Options Held
6.3K-
Trigran Investments, Inc.2.07MShares$52.5 Million5.1% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$39.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX810KShares$20.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA774KShares$19.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny560KShares$14.2 Million0.02% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $370M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...